Objective:

To value the complications and sequels for patients with Lisfranc’s fracture-luxation (FLL).

Material and methods:

A transverse ambispective study of cohorts was realized of 83 patients by diagnosis of Lisfranc’s fracture-luxation. There was in use a protocol of withdrawal of information with variables related to the injury, clinical, therapeutic parameters, complications and scales of clinical valuation.

Results:

66 patients (79.5%) presented complications grouping early and late. Analyzing the early complications, we observe 9 cases of postoperatory edema with inflammation and swelling, 3 cases of superficial infection, 2 cases of necrosis cutaneous that precise graft should free of skin (ILPH), 1 case of vascular complication, 1 case of pulmonary embolis (TEP), 1 case of loss of reduction in the precocious postoperatory, 1 case of bad reduction that was necessary new intervention. The late complications presented the following distribution: 41 patients (49.40%) presented radiological signs of degenerative osteoarthritis in the tarsometatarsal joint, 5 cases of Sudeck’s disease that needed treatment, 8 cases of decalcification for disuse, 12 cases of edema and residual inflammation, 1 case of loss of reduction in late phase, 1 case of hypertrophic scar with retractable bridle, 1 case of chronic osteomyelitis, 1 case of seudodegenerative osteoarthritis, 3 cases of late intolerance/infection to the osteosynthesis material, reintervention of 7 patients in phase of sequels where they were realized artrodesis. No break of material was observed of osteosynthesis. Almost the half of the patients (49.4%) they received some type of economic indemnification after the accident.

Conclusions:

The treatment of the FLL must be realized as soon as possible, providing that the general condition of the patient and of the soft parts allows it, since the stabilization in the brief space of time can help to improve the results. The anatomical reduction cannot grant a good result. An important number of patients had residual pain.